Hugo Juárez-Olguín

16PUBLICATIONS
12CO-AUTHORS
Gene and molecular therapyAnimal protection (incl. pests and pathogens)Disease surveillanceBiologically active moleculesCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (16)

|Jul 29, 2026
Modern Trends in the Development of Natural and Synthetic Anti-Tuberculosis Drugs.

|Jul 16, 2026
Therapeutic potential of flavonoids and rutin against inflammation-induced on a huntington animal model.

|May 23, 2026
Post COVID-19 treated with AstraZeneca vaccine exacerbates arthritis with susceptibility to herpes in an older woman: A case report.

|Jan 30, 2026
Novel Synthetic Steroid Derivatives: Target Prediction and Biological Evaluation of Antiandrogenic Activity.

David Calderón Guzmán, Norma Osnaya Brizuela, Hugo Juárez Olguín

|Jun 19, 2024
N-Acetylcysteine Attenuates Cisplatin Toxicity in the Cerebrum and Lung of Young Rats with Artificially Induced Protein Deficiency.

David Calderón Guzmán, Norma Osnaya Brizuela, Maribel Ortíz Herrera

|May 12, 2024
Intake of oligoelements with cytarabine or etoposide alters dopamine levels and oxidative damage in rat brain.

David Calderón Guzmán, Norma Osnaya Brizuela, Maribel Ortíz Herrera

Pageof 3

Frequent Collaborators

3 joint publications

Daniel Santamaria Del Angel

2 joint publications

Gerardo Barragán Mejía

2 joint publications

Norma Osnaya Brizuela

2 joint publications

Alberto Rojas Ochoa